SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) or (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BioTime, Inc.
(Exact name of registrant as specified in its charter)
California 94-3127919
(State of incorporation or organization) (I.R.S. Employer Identification No.)
935 Pardee Street, Berkeley, California 94710
(Address of Principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
------------------- ------------------------------
Common Shares, no par value American Stock Exchange, Inc.
If this form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box.[x]
If this form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), check the following box.[ ]
Securities Act registration statement file number to which this form relates:
Not applicable.
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
<PAGE>
Item 1. Description of Registrant's Securities to be Registered.
The description of the Registrant's Common Shares, no par value, is
incorporated by reference to the Prospectus contained in Registrant's
Registration Statement on Form S-3, No. 333-69179, filed with the Commission on
December 18, 1998. Any prospectus filed under Rule 424(b) under the Securities
Act with respect to such Registration Statement shall be deemed to be
incorporated by reference into this registration statement.
Item 2. Exhibits.
1. A copy of the certificate for the security being registered is included
as Exhibit 4(a) to Registrant's Registration Statement on Form S-1, No.
33-44549, filed with the Commission on December 18, 1991, and Amendment
No. 1 and Amendment No. 2 thereto filed with the Securities and
Exchange Commission on February 6, 1992 and March 7, 1992,
respectively, which exhibit is incorporated herein by reference.
2. Articles of Incorporation, as amended, are included as Exhibit 3.1 to
Registrant's Annual Report on Form 10-K for the fiscal year ended June
30, 1998, which exhibit is incorporated herein by reference.
3. Bylaws, as amended, are included as Exhibit 3(c) to Registrant's
Registration Statement on Form S-1, No. 33-48717 and Post-Effective
Amendment No. 1 thereto, filed with the Securities and Exchange
Commission on June 22, 1992 and August 27, 1992, respectively, which
exhibit is incorporated herein by reference.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereto duly authorized.
Date: August 30, 1999. BioTime, Inc.
By /s/Paul Segall
------------------------------------
Paul Segall, Chief Executive Officer
